Literature DB >> 8550226

Listeriolysin is a potent inducer of the phosphatidylinositol response and lipid mediator generation in human endothelial cells.

U Sibelius1, F Rose, T Chakraborty, A Darji, J Wehland, S Weiss, W Seeger, F Grimminger.   

Abstract

The impact of Listeria monocytogenes listeriolysin O (LLO) secretion on phosphoinositide metabolism and mediator (platelet-activating factor and prostaglandin I2) generation was investigated in human umbilical vein endothelial cells. Wild-type L. monocytogenes, purified LLO, and an L. innocua strain engineered to secrete LLO all elicited a strong response, whereas mutant strains defective in LLO production were ineffective. Thus, human umbilical vein endothelial cell stimulation by listeriae is linked to production of LLO.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8550226      PMCID： PMC173820          DOI： 10.1128/iai.64.2.674-676.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  16 in total

1.  Two types of G proteins involved in regulation of phosphoinositide turnover in pulmonary endothelial cells.

Authors:  V A Tkachuk; T A Voyno-Yasenetskaya
Journal:  Am J Physiol       Date:  1991-10

Review 2.  Listeriosis.

Authors:  B G Gellin; C V Broome
Journal:  JAMA       Date:  1989-03-03       Impact factor: 56.272

3.  Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils.

Authors:  R N Pinckard; R S Farr; D J Hanahan
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

4.  Release of leukotrienes into the perfusate of calcium-ionophore stimulated rabbit lungs. Influence of 5-lipoxygenase inhibitors.

Authors:  R Schulz; W Seeger
Journal:  Biochem Pharmacol       Date:  1986-01-15       Impact factor: 5.858

5.  Stimulation of platelet-activating factor synthesis by a nonmetabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites.

Authors:  T G Tessner; J T O'Flaherty; R L Wykle
Journal:  J Biol Chem       Date:  1989-03-25       Impact factor: 5.157

6.  Identification of a gene that positively regulates expression of listeriolysin, the major virulence factor of listeria monocytogenes.

Authors:  M Leimeister-Wächter; C Haffner; E Domann; W Goebel; T Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

7.  Escherichia coli hemolysin is a potent inductor of phosphoinositide hydrolysis and related metabolic responses in human neutrophils.

Authors:  F Grimminger; U Sibelius; S Bhakdi; N Suttorp; W Seeger
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

8.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

9.  Role of phosphoinositides in the regulation of endothelial prostacyclin production.

Authors:  H Halldórsson; M Kjeld; G Thorgeirsson
Journal:  Arteriosclerosis       Date:  1988 Mar-Apr

10.  Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides.

Authors:  M J Berridge; R M Dawson; C P Downes; J P Heslop; R F Irvine
Journal:  Biochem J       Date:  1983-05-15       Impact factor: 3.857
View more
  20 in total

1.  Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity.

Authors:  Hisashi Baba; Ikuo Kawamura; Chikara Kohda; Takamasa Nomura; Yutaka Ito; Terumi Kimoto; Isao Watanabe; Satoshi Ichiyama; Masao Mitsuyama
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

Review 2.  Listeriolysin O: from bazooka to Swiss army knife.

Authors:  Suzanne E Osborne; John H Brumell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-08-05       Impact factor: 6.237

Review 3.  Listeria pathogenesis and molecular virulence determinants.

Authors:  J A Vázquez-Boland; M Kuhn; P Berche; T Chakraborty; G Domínguez-Bernal; W Goebel; B González-Zorn; J Wehland; J Kreft
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

4.  Mutagenesis of active-site histidines of Listeria monocytogenes phosphatidylinositol-specific phospholipase C: effects on enzyme activity and biological function.

Authors:  T Bannam; H Goldfine
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

5.  Neutralizing monoclonal antibodies against listeriolysin: mapping of epitopes involved in pore formation.

Authors:  A Darji; K Niebuhr; M Hense; J Wehland; T Chakraborty; S Weiss
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

6.  Human endothelial cell activation and mediator release in response to Listeria monocytogenes virulence factors.

Authors:  F Rose; S A Zeller; T Chakraborty; E Domann; T Machleidt; M Kronke; W Seeger; F Grimminger; U Sibelius
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 7.  Invasion of the central nervous system by intracellular bacteria.

Authors:  Douglas A Drevets; Pieter J M Leenen; Ronald A Greenfield
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  Rhombencephalitis Caused by Listeria monocytogenes in Humans and Ruminants: A Zoonosis on the Rise?

Authors:  Anna Oevermann; Andreas Zurbriggen; Marc Vandevelde
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-28

9.  Listeria monocytogenes phosphatidylinositol-specific phospholipase C: Kinetic activation and homing in on different interfaces.

Authors:  Wei Chen; Howard Goldfine; Bharath Ananthanarayanan; Wonhwa Cho; Mary F Roberts
Journal:  Biochemistry       Date:  2009-04-28       Impact factor: 3.162

10.  The role of cholesterol in the activity of pneumolysin, a bacterial protein toxin.

Authors:  Marcelo Nöllmann; Robert Gilbert; Timothy Mitchell; Michele Sferrazza; Olwyn Byron
Journal:  Biophys J       Date:  2004-05       Impact factor: 4.033
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.